Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations

American Journal of Epidemiology

Volumn 177, Issue 9, 2013, Pages 923-932

  Zhang, Lili ^a   Spencer, Kylee L ^b   Voruganti, V Saroja ^c   Jorgensen, Neal W ^d   Fornage, Myriam ^e   Best, Lyle G ^f   Brown Gentry, Kristin D ^b   Cole, Shelley A ^c   Crawford, Dana C ^b   Deelman, Ewa ^g   Franceschini, Nora ^h   Gaffo, Angelo L ⁱ   Glenn, Kimberly R ^b   Heiss, Gerardo ^h   Jenny, Nancy S ^j   Kottgen, Anna ^a,k   Li, Qiong ^b   Liu, Kiang ^l   Matise, Tara C ^m   North, Kari E ^h   Umans, Jason G ⁿ   Kao, W H Linda ^a   more..

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f MISSOURI BREAKS INDUSTRIES RESEARCH INC   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h IL   (United States)

ⁱ The University of Alabama at Birmingham   (United States)

^j UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF FREIBURG   (Germany)

^l NORTHWESTERN UNIVERSITY   (United States)

^m RUTGERS UNIVERSITY   (United States)

ⁿ MEDSTAR RESEARCH INSTITUTE   (United States)

more..

Author keywords

ABCG2 protein, human; genetic association studies; gout; meta analysis; polymorphism, single nucleotide; urate transporter; uric acid

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; URIC ACID;

DISEASE TREATMENT; EPIDEMIOLOGY; GENE; GENOMICS; GENOTYPE; HORMONE; MUTATION; POLYMORPHISM; SERUM; SEX HORMONE;

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; BODY MASS; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GOUT; HISPANIC; HORMONAL THERAPY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POPULATION; POSTMENOPAUSE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; URIC ACID BLOOD LEVEL;

ABCG2 PROTEIN, HUMAN; GENETIC ASSOCIATION STUDIES; GOUT; META-ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; URATE TRANSPORTER; URIC ACID;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; ATP-BINDING CASSETTE TRANSPORTERS; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOME-WIDE ASSOCIATION STUDY; GOUT; HORMONE REPLACEMENT THERAPY; HUMANS; INDIANS, NORTH AMERICAN; MALE; MEXICAN AMERICANS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; POSTMENOPAUSE; SEX DISTRIBUTION; UNITED STATES; URIC ACID;

UNITED STATES;

EID: 84877257399     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws330     Document Type: Article

References (49)

1. Richette P, Bardin T. Gout. Lancet. 2010;375(9711):318-328.
2. Roddy E, Zhang W, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol. 2007;3(8):443-449.
3. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26-35.
4. Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the United States. J Rheumatol. 2008;35(3): 498-501.
5. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62(2):170-180.
6. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811-1821.
7. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183-1190.
8. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10. 1999;(200):1-203.
9. Weaver AL. Epidemiology of gout. Cleve Clin J Med. 2008; 75(suppl 5):S9-S12.
10. Yang Q, Guo CY, Cupples LA, et al. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism. 2005;54(11):1435-1441.
11. Li S, Sanna S, Maschio A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 2007;3(11):e194.
12. Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008; 40(4):437-442.
13. Doring A, Gieger C, Mehta D, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008;40(4):430-436.
14. Dehghan A, Kottgen A, Yang Q, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654): 1953-1961.
15. Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28, 141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5(6): e1000504.
16. Wallace C, Newhouse SJ, Braund P, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008;82(1):139-149.
17. Stark K, Reinhard W, Grassl M, et al. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One. 2009;4(11):e7729.
18. Brandstatter A, Lamina C, Kiechl S, et al. Sex and age interaction with genetic association of atherogenic uric acid concentrations. Atherosclerosis. 2010;210(2):474-478.
19. Yamagishi K, Tanigawa T, Kitamura A, et al. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people. Rheumatology (Oxford). 2010;49(8):1461-1465.
20. Tabara Y, Kohara K, Kawamoto R, et al. Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study. Am J Nephrol. 2010;32(3):279-286.
21. Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, et al. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample sets. Hum Mol Genet. 2010;19(24): 4813-4819.
22. Matsuo H, Takada T, Ichida K, et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med. 2009;1(5):5ra11.
23. Woodward OM, Kottgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA. 2009;106(25):10338-10342.
24. Matise TC, Ambite JL, Buyske S, et al. The next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. Am J Epidemiol. 2011;174(7):849-859
25. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
26. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105-1116.
27. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991; 1(3):263-276.
28. Lee ET, Welty TK, Fabsitz R, et al. The Strong Heart Study: a study of cardiovascular disease in American Indians. Design and methods. Am J Epidemiol. 1990;132(6):1141-1155.
29. Voruganti VS, Goring HH, Mottl A, et al. Genetic influence on variation in serum uric acid in American Indians: the Strong Heart Family Study. Hum Genet. 2009;126(5): 667-676.
30. North KE, Howard BV, Welty TK, et al. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the Strong Heart Family Study. Am J Epidemiol. 2003;157(4):303-314.
31. Samani NJ, Raitakari OT, Sipila K, et al. Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28(9):1679-1683.
32. McAdams MA, Maynard JW, Baer AN, et al. Reliability and sensitivity of the self-report of physician-diagnosed gout in the Campaign Against Cancer and Heart Disease and the Atherosclerosis Risk in the Community cohorts. J Rheumatol. 2011;38(1):135-141.
33. Boerwinkle E, Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet. 1986;50(2):181-194.
34. Dempfle A, Scherag A, Hein R, et al. Gene-environment interactions for complex traits: definitions, methodological requirements and challenges. Eur J Hum Genet. 2008; 16(10):1164-1172.
35. Ye S, Willeit J, Kronenberg F, et al. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol. 2008;52(5):378-384.
36. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4): 459-467.
37. Kottgen A, Glazer NL, Dehghan A, et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet. 2009;41(6):712-717.
38. North KE, Goring HH, Cole SA, et al. Linkage analysis of LDL cholesterol in American Indian populations: the Strong Heart Family Study. J Lipid Res. 2006;47(1):59-66.
39. Havill LM, Dyer TD, Richardson DK, et al. The quantitative trait linkage disequilibrium test: a more powerful alternative to the quantitative transmission disequilibrium test for use in the absence of population stratification. BMC Genet. 2005; 6(suppl 1):S91.
40. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol. 1997;14(6): 959-964.
41. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62(5): 1198-1211.
42. Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93-111.
43. Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA. 1998;95(26):15665-15670.
44. Imai Y, Tsukahara S, Ishikawa E, et al. Estrone and 17β-estradiol reverse breast cancer resistance protein-mediated multidrug resistance. Jpn J Cancer Res. 2002;93(3): 231-235.
45. Imai Y, Ishikawa E, Asada S, et al. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res. 2005;65(2):596-604.
46. Wang H, Unadkat JD, Mao Q. Hormonal regulation of BCRP expression in human placental BeWo cells. Pharm Res. 2008;25(2):444-452.
47. Hartz AM, Mahringer A, Miller DS, et al. 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity. J Cereb Blood Flow Metab. 2010;30(10):1742-1755.
48. Merino G, van Herwaarden AE, Wagenaar E, et al. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol Pharmacol. 2005;67(5):1765-1771.
49. Tanaka Y, Slitt AL, Leazer TM, et al. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochem Biophys Res Commun. 2005;326(1):181-187.